CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells - Wikidata - wikimedia - TriplyDB

CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells

CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells

http://www.wikidata.org/entity/Q30484805

about

Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule The pathogenesis of chronic lymphocytic leukemia The PI3K p110δ regulates expression of CD38 on regulatory T cells Morphology and expression status investigations of specific surface markers on B-cell chronic lymphocytic leukemia cells.The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia PECAM1(+)/Sca1(+)/CD38(+) vascular cells transform into myofibroblast-like cells in skin wound repair.Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.Human CD38hiCD138⁺ plasma cells can be generated in vitro from CD40-activated switched-memory B lymphocytes TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.CD38 and chronic lymphocytic leukemia: a decade later.Immuno-targeting the multifunctional CD38 using nanobody A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model.Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.CD38 is a putative functional marker for side population cells in human nasopharyngeal carcinoma cell lines.Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia.CD38 and interleukin 6 gene polymorphism in egyptians with diffuse large B-cell lymphoma (DLBCL).CD38 signals upregulate expression and functions of matrix metalloproteinase-9 in chronic lymphocytic leukemia cells.Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38+ tumors in mouse models in vivo.The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting.

P2860

Q27015933-72BC9EC4-C621-41C8-9AFE-AF2965C2298E Q27025715-620F32DD-93C0-4440-A592-47460CED45AF Q28742303-469047CE-A5D3-437E-8F09-3E51CA74D22E Q31126777-DF115DD5-8657-45FE-AE7A-F0F02A919F8E Q33655756-9C258494-5835-4EE9-9981-5CB4AD4FC1EF Q34544850-6356742B-BE9E-41B7-B44D-695A23CDE8F8 Q35020381-4AF98814-2267-4B0F-89E3-0ADFF61EE5D0 Q35156154-17107404-9808-4B27-90D7-72B4B8107FAB Q35861964-336E0AA2-91B8-45F8-A3F4-E2BE6C202985 Q36236545-90101AB3-8389-43F8-A312-E24F9F53D230 Q36615126-30B322EC-149D-42DD-9F95-E5E035297CBD Q36959363-5695E192-09EA-471E-9616-89F839EB0D87 Q37054037-1CD99FF3-F917-4887-931B-E47784631C5F Q37868181-0272617B-E0B8-4B2F-85BC-671CDAD22F9C Q37876541-16A8AE33-897F-495F-BE5D-7EC41B772B8A Q37910914-86F225E2-681F-4428-AE8A-1D56DC585341 Q38915605-404E4511-0F21-4D4E-BFF3-F304FAD5571D Q39092611-DC7EBCE2-E60C-495D-8C37-66B126F90FA1 Q39506851-DF20BE92-1423-41D1-A565-0D921227845B Q44631185-14014188-5825-4143-9257-BDFBC859C83C Q47155090-0113CCE7-A989-4B57-904D-268B36334A12 Q53271932-7D020685-1FBA-4B5C-9976-12FBA83E58C7

P2860

CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells

http://www.wikidata.org/entity/Q30484805

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

CD38/CD31 interactions activat ...... nic lymphocytic leukemia cells

@ast

CD38/CD31 interactions activat ...... nic lymphocytic leukemia cells

@en

type

label

CD38/CD31 interactions activat ...... nic lymphocytic leukemia cells

@ast

CD38/CD31 interactions activat ...... nic lymphocytic leukemia cells

@en

prefLabel

CD38/CD31 interactions activat ...... nic lymphocytic leukemia cells

@ast

CD38/CD31 interactions activat ...... nic lymphocytic leukemia cells

@en

P1433

Q30484805-1B56B2F3-37EB-4C43-BAF7-E234AD04C88B

P1476

Q30484805-61EBEA24-798A-44D1-B404-BDB8D44AED31

P2093

Q30484805-B174E3FB-A91A-4A92-A128-4C5B10E2B401

Q30484805-C1608B25-2F84-44FF-A594-64620B28916B

Q30484805-C210D76E-5C6D-4D9C-BA9C-1C2BA15CF981

Q30484805-F700F98B-F54D-4BD3-806E-73D6C3DCA67E

Q30484805-F9A7CF63-D057-46A9-BFB4-D675736DD192

P2860

Q30484805-04FA7B28-99C3-4882-8396-09EF62589346

Q30484805-0BDD6C2F-6D3A-4C0B-986C-85853DB53385

Q30484805-1A72AAA8-C054-4C53-90B7-5C696E979DD2

Q30484805-326D95C5-9368-4FC2-84C4-FCB348167476

Q30484805-38FED22E-7D6A-45DB-99B5-8A984345150E

Q30484805-3C02E27B-434A-4CCE-85D8-D09063252CB0

Q30484805-4A77F735-5E03-4958-8523-408E09B8740E

Q30484805-5034C297-B506-47E5-A248-B9886745EE6D

Q30484805-642FF37B-1446-4091-B277-C531E605359D

Q30484805-80E6E8A4-50EF-4DB1-9B33-758BFB7ED121

P2888

Q30484805-90965B27-613C-4DD6-A2E6-2AEAF06E3E43

P304

Q30484805-83CA7C13-2913-44EA-9FE3-35A227719E5D

P31

Q30484805-D58BA255-3774-40E7-A237-46C0D8AC057B

P356

Q30484805-6E465885-A162-42C7-BA9B-078BA9836941

P407

Q30484805-782CDB89-597D-45D6-AAA1-E32B13018C19

P433

Q30484805-DD2DDBF1-36E4-4074-8068-4962EC892750

P478

Q30484805-9FCF4240-45BB-402B-909D-5776D31CC867

P50

Q30484805-0BE143DF-3A96-4D0F-B1A5-96B6172B05E5

Q30484805-8DCE1199-46A2-4369-AAFB-0A67145D439F

Q30484805-A8E39300-6DD0-4DA5-8A55-FFE8580F6765

P577

Q30484805-FD613ACC-868D-41F0-9712-6B5BC4218FE0

P5875

Q30484805-FC585715-46F9-4D68-9DDE-2FC542D94990

P6179

Q30484805-9E3EF575-63D2-41ED-B3BA-D22C0560B0F6

P698

Q30484805-6ED90842-5C25-4670-991A-FE97CE4B8D72

P921

Q30484805-100567F8-2F30-4FDE-8473-89B7A5E21FF0

Q30484805-2F5D9626-E06F-4993-AE20-A09A7D66D012

P932

Q30484805-36809D36-23BB-401B-895D-ED501A8673C4

P356

MOLMED.2009.00146

P1433

Molecular Medicine

P1476

CD38/CD31 interactions activat ...... nic lymphocytic leukemia cells

@en

P2093

Giovanni D'Arena

http://www.w3.org/2001/XMLSchema#string

Luciana Bergui

http://www.w3.org/2001/XMLSchema#string

Maurizia Mello Grand

http://www.w3.org/2001/XMLSchema#string

Semra Aydin

http://www.w3.org/2001/XMLSchema#string

Silvia Deaglio

http://www.w3.org/2001/XMLSchema#string

P2860

CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

Pathway level analysis of gene expression using singular value decomposition

Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member

Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes.

CD38 as a prognostic marker in CLL.

CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.

The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia.

In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.

P2888

molmed.2009.00146

P304

87-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2119/MOLMED.2009.00146

http://www.w3.org/2001/XMLSchema#string

P407

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Giovanna Chiorino

Tiziana Vaisitti

P577

2009-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40443641

http://www.w3.org/2001/XMLSchema#string

P6179

1068965230

http://www.w3.org/2001/XMLSchema#string

P698

19956559

http://www.w3.org/2001/XMLSchema#string

P921

P932

2785473

http://www.w3.org/2001/XMLSchema#string